CN101984983B - 独一味提取物、含有该提取物的药物组合物的检测方法 - Google Patents
独一味提取物、含有该提取物的药物组合物的检测方法 Download PDFInfo
- Publication number
- CN101984983B CN101984983B CN 201010244991 CN201010244991A CN101984983B CN 101984983 B CN101984983 B CN 101984983B CN 201010244991 CN201010244991 CN 201010244991 CN 201010244991 A CN201010244991 A CN 201010244991A CN 101984983 B CN101984983 B CN 101984983B
- Authority
- CN
- China
- Prior art keywords
- cape jasmine
- methyl esters
- jasmine glycosides
- mountain cape
- glycosides methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001191006 Phlomoides rotata Species 0.000 title claims abstract description 69
- 239000000284 extract Substances 0.000 title claims abstract description 60
- 238000001514 detection method Methods 0.000 title claims description 14
- 239000003814 drug Substances 0.000 title abstract description 33
- 239000000203 mixture Substances 0.000 title abstract description 5
- 238000012360 testing method Methods 0.000 claims abstract description 81
- 239000000463 material Substances 0.000 claims abstract description 53
- 238000000034 method Methods 0.000 claims abstract description 49
- 238000002360 preparation method Methods 0.000 claims abstract description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 306
- -1 glycosides methyl esters Chemical class 0.000 claims description 212
- 229930182470 glycoside Natural products 0.000 claims description 210
- 244000111489 Gardenia augusta Species 0.000 claims description 209
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 209
- 239000000243 solution Substances 0.000 claims description 58
- 239000013558 reference substance Substances 0.000 claims description 56
- 239000012467 final product Substances 0.000 claims description 46
- 238000010992 reflux Methods 0.000 claims description 42
- 239000002775 capsule Substances 0.000 claims description 40
- 239000000706 filtrate Substances 0.000 claims description 36
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000010828 elution Methods 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 14
- 238000005303 weighing Methods 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 9
- 239000000945 filler Substances 0.000 claims description 7
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 7
- 239000000377 silicon dioxide Substances 0.000 claims description 7
- 238000003908 quality control method Methods 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 8
- 230000000857 drug effect Effects 0.000 abstract description 8
- KKSYAZCUYVRKML-IRDZEPHTSA-N Shanzhiside methyl ester Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@@](C[C@H]2O)(C)O)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KKSYAZCUYVRKML-IRDZEPHTSA-N 0.000 abstract 5
- SCXMMKUKDINSDI-UHFFFAOYSA-N shanzhiside methyl ester Natural products COC(=O)C1=CCC(OC2OC(CO)C(O)C(O)C2O)C3C1C(O)CC3(C)O SCXMMKUKDINSDI-UHFFFAOYSA-N 0.000 abstract 5
- ARFRZOLTIRQFCI-UHFFFAOYSA-N 3,6,9,12,15,18-Heneicosahexaene Natural products OC1CC(OC(C)=O)(C)C2C1C(C(=O)OC)=COC2OC1OC(CO)C(O)C(O)C1O ARFRZOLTIRQFCI-UHFFFAOYSA-N 0.000 abstract 4
- ARFRZOLTIRQFCI-NGQYDJQZSA-N methyl (1s,4as,5r,7s,7as)-7-acetyloxy-5-hydroxy-7-methyl-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@@](C[C@H]2O)(C)OC(C)=O)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ARFRZOLTIRQFCI-NGQYDJQZSA-N 0.000 abstract 4
- 239000003550 marker Substances 0.000 abstract 2
- 238000003556 assay Methods 0.000 description 24
- 238000011084 recovery Methods 0.000 description 22
- 238000000605 extraction Methods 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000843 powder Substances 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 8
- 239000002504 physiological saline solution Substances 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 238000004811 liquid chromatography Methods 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000000740 bleeding effect Effects 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 229930182489 iridoid glycoside Natural products 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- 238000012372 quality testing Methods 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000009306 yunnan baiyao Substances 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- 206010014025 Ear swelling Diseases 0.000 description 2
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960003657 dexamethasone acetate Drugs 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000010829 isocratic elution Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000005325 percolation Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 101100340946 Mus musculus Impact gene Proteins 0.000 description 1
- 101100203936 Mus musculus Srpra gene Proteins 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010244991 CN101984983B (zh) | 2009-07-28 | 2010-07-27 | 独一味提取物、含有该提取物的药物组合物的检测方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910060134.1 | 2009-07-28 | ||
CN200910060134A CN101612192A (zh) | 2009-07-28 | 2009-07-28 | 独一味提取物、含有该提取物的药物组合物及质量控制方法 |
CN 201010244991 CN101984983B (zh) | 2009-07-28 | 2010-07-27 | 独一味提取物、含有该提取物的药物组合物的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101984983A CN101984983A (zh) | 2011-03-16 |
CN101984983B true CN101984983B (zh) | 2013-03-13 |
Family
ID=41492200
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910060134A Pending CN101612192A (zh) | 2009-07-28 | 2009-07-28 | 独一味提取物、含有该提取物的药物组合物及质量控制方法 |
CN 201010244991 Active CN101984983B (zh) | 2009-07-28 | 2010-07-27 | 独一味提取物、含有该提取物的药物组合物的检测方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910060134A Pending CN101612192A (zh) | 2009-07-28 | 2009-07-28 | 独一味提取物、含有该提取物的药物组合物及质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN101612192A (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102397324B (zh) * | 2010-09-10 | 2013-11-27 | 中国科学院兰州化学物理研究所 | 藏药独一味中苯丙素苷类物质的测定方法 |
CN103130849B (zh) * | 2011-11-29 | 2016-04-06 | 河南科技大学 | 一种制备8-乙酰山栀苷甲酯的方法 |
CN103083395B (zh) * | 2012-12-31 | 2015-03-25 | 安徽海神寿春药业有限公司 | 一种独一味干浸膏的制备方法 |
CN103655689A (zh) * | 2013-12-24 | 2014-03-26 | 江西南昌制药有限公司 | 独一味提取物的制备方法 |
CN103655690A (zh) * | 2013-12-24 | 2014-03-26 | 江西南昌制药有限公司 | 一种治疗活血止痛、化瘀止血药的制备方法 |
CN104237441B (zh) * | 2014-10-09 | 2015-07-22 | 成都中医药大学 | 同时检测独一味中环烯醚萜苷、苯乙醇苷、黄酮、咖啡酰类成分的方法 |
CN106324119B (zh) * | 2016-08-08 | 2019-03-29 | 成都医学院 | 同时测定独一味药材中8种成分的uplc方法 |
CN111272910A (zh) * | 2018-12-05 | 2020-06-12 | 九芝堂股份有限公司 | Hplc测定马缨丹药材中山栀苷甲酯的方法 |
CN112946151B (zh) * | 2019-12-10 | 2024-02-23 | 海南九芝堂药业有限公司 | 一种复方马缨丹片的检测方法 |
CN111803463A (zh) * | 2020-06-18 | 2020-10-23 | 中南民族大学 | 一种藏药复方乳藤胶囊及其制备方法和质量标准检测方法 |
CN115317531A (zh) * | 2022-05-16 | 2022-11-11 | 天津中医药大学 | 一种独一味提取物、制剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101308123A (zh) * | 2008-07-01 | 2008-11-19 | 李茂星 | 液相色谱法测定独一味中8-o-乙酰基山栀子苷甲酯含量的方法 |
-
2009
- 2009-07-28 CN CN200910060134A patent/CN101612192A/zh active Pending
-
2010
- 2010-07-27 CN CN 201010244991 patent/CN101984983B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101308123A (zh) * | 2008-07-01 | 2008-11-19 | 李茂星 | 液相色谱法测定独一味中8-o-乙酰基山栀子苷甲酯含量的方法 |
Non-Patent Citations (2)
Title |
---|
国家药典委员会.独一味胶囊.《中华人民共和国药典》.化学工业出版社,2005,541. * |
李茂星等.藏药独一味中总环烯醚萜苷的含量测定.《华西药学杂志》.2007,第22卷(第2期),208-210. * |
Also Published As
Publication number | Publication date |
---|---|
CN101612192A (zh) | 2009-12-30 |
CN101984983A (zh) | 2011-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101984983B (zh) | 独一味提取物、含有该提取物的药物组合物的检测方法 | |
CN103207255B (zh) | 一种脑心通胶囊的含量检测方法 | |
CN104730171B (zh) | 一种中药复方制剂中赤芍、金银花多指标成分含量测定方法 | |
CN103816296A (zh) | 紫珠总苷提取物及其制备方法和用途 | |
Yang et al. | A strategy based on liquid-liquid-refining extraction and high-speed counter-current chromatography for the bioassay-guided separation of active compound from Taraxacum mongolicum | |
CN103149310A (zh) | 参芎葡萄糖注射液原料、中间体及其制剂的指纹图谱建立方法和质量控制方法 | |
CN105911192B (zh) | 一种半枫荷活血化瘀活性部位的提取方法及指纹图谱检测方法 | |
CN102539599B (zh) | 一种强肝药物的检测方法 | |
CN101961405B (zh) | 检测复方杜仲片中松脂醇二葡萄糖苷含量的方法 | |
CN105434555A (zh) | 一种热淋清制剂的制作方法 | |
CN103550237B (zh) | 一种茜草活性成分组合物及其在医药上的应用 | |
CN103940942B (zh) | 一种肠炎宁制剂的检测方法 | |
CN100453080C (zh) | 乌药生物碱及其制备方法与在制药中的应用 | |
CN101732405B (zh) | 独一味提取物、含有该提取物的药物组合物的质量检测方法 | |
CN110687219B (zh) | 一种苏黄止咳胶囊指纹图谱的检测方法及其应用 | |
CN113820422A (zh) | 一种白芍总苷指纹图谱检测方法 | |
CN104020225B (zh) | 生血宝制剂特征图谱及其建立方法 | |
CN102590423A (zh) | 川芎茶调颗粒制剂指纹图谱的测定方法 | |
CN102988500B (zh) | 一种复方胆通片的制备方法及应用 | |
CN100368806C (zh) | 一种检测紫花前胡素的方法 | |
CN101317941B (zh) | 一种利尿镇痛的药物 | |
CN100411653C (zh) | 一种治疗糖尿病的中药组合物及其制剂和用途 | |
CN102590368B (zh) | 一种八角枫碱的含量测定方法 | |
CN104383547A (zh) | 天山雪莲提取物磷脂复合物、口腔崩解片及其制备方法 | |
CN102512416A (zh) | 一种含有脱氢延胡索碱的药物组合物及制备方法和测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: HENGKANG MEDICAL GROUP CO., LTD. Free format text: FORMER NAME: GANSU DUYIWEI BIOLOGICAL PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 610063 No. 456 Jinshi Road, Jinjiang Industrial Development Zone, Sichuan, Chengdu Patentee after: HENGKANG MEDICAL GROUP CO.,LTD. Address before: 610063 No. 456 Jinshi Road, Jinjiang Industrial Development Zone, Sichuan, Chengdu Patentee before: GANSU DUYIWEI BIOLOGICAL PHARMACEUTICAL Co.,Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 746500 Gansu city of Longnan Province Wang Kang dam Duyiwei Industrial Park Patentee after: HENGKANG MEDICAL GROUP CO.,LTD. Address before: 610063 No. 456 Jinshi Road, Jinjiang Industrial Development Zone, Sichuan, Chengdu Patentee before: HENGKANG MEDICAL GROUP CO.,LTD. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 746500 Wang Yi Industrial Park, Wang Ba, Kang County, Longnan, Gansu Patentee after: New Journey Health Technology Group Co.,Ltd. Address before: 746500 Wang Yi Industrial Park, Wang Ba, Kang County, Longnan, Gansu Patentee before: HENGKANG MEDICAL GROUP CO.,LTD. |